PTAB Axes Antecip IP, Rejects Its Printed Publication Stance

By Britain Eakin (July 30, 2020, 5:44 PM EDT) -- The Patent Trial and Appeal Board has invalidated three Antecip Bioventures pain treatment patents, shooting down its argument that German rival Grunenthal GmbH didn't do enough at the institution stage to prove that five printed publications qualify as prior art....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!